Wednesday, February 24 th, 2016
|
|
|
- Mervin Shields
- 6 years ago
- Views:
Transcription
1
2 List of Faculty: Nadeem R. Abu-Rustum, Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy Natalia Carballo, Carlos Centeno, Clínica Universidad de Navarra. Pamplona, Spain David Cibula, General University Hospital in Prague, Charles University. Prague, The Czech Republic Robert L. Coleman, Nicoletta Colombo, Istituto Europeo di Oncologia. Milan, Italy Luis M. Chiva, Ben Davidson, The Norwegian Radium Hospital. Oslo, Norway Andreas du Bois, Kliniken Essen Mitte. Essen, Germany Pedro F. Escobar, Instituto Gyneco-Oncológico. San Juan, Puerto Rico Anna Fagotti, Catholic University of the Sacred Heart. Rome, Italy Michael M. Frumovitz, Juan Fernando García, David M. Gershenson, Antonio González-Martín, Anuja Jhingran, Matías Jurado, Clínica Universidad de Navarra. Pamplona, Spain Fernando Lapuente, Jonathan A. Ledermann, UCL Cancer Institute, University College. London, United Kingdom Mario M. Leitao, Karen H. Lu, Andrea Mariani, Mayo Clinic, Rochester. Minnesota, USA Christian Marth, Medical University Innsbruck, Austria Sergio Martínez, Hospital Clínic Universitari. Barcelona, Spain Ignacio Melero, Clínica Universidad de Navarra. Pamplona, Spain Mansoor R. Mirza, Rigshospitalet, Copenhagen University Hospital. Copenhagen, Denmark Gema Moreno, Ana Oaknin, Hospital General Vall d Hebron. Barcelona, Spain José Palacios, Hospital Universitario Ramón y Cajal. Madrid, Spain Sandro Pignata, National Cancer Institute Fondazione Pascale. Naples, Italy Jordi Ponce, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat. Barcelona, Spain Andrés Poveda, Fundación Instituto Valenciano de Oncología. Valencia, Spain Eric Pujade-Lauraine, Hôpital Hôtel-Dieu. Paris, France Denis Querleu, Institut Bergonié. Bordeaux, France Pedro T. Ramirez, Andrés Redondo, Hospital Universitario La Paz. Madrid, Spain Ignacio Romero, Fundación Instituto Valenciano de Oncología. Valencia, Spain Anil Sood, Ate Van der Zee, University Medical Center of Groningen, Netherlands 12:00 12:15 WELCOME REMARKS DEALING WITH RARE OVARIAN TUMORS 12:15-12:35 Updates on novel therapies for rare tumors: From chemotherapy to innovative therapies Dr. David Gershenson 12:35-12:55 Overview of histopathologic classifications of rare tumors Dr. Juan Fernando García 12:55-13:20 Discussion 13:20-15:00 Lunch Moderator: KEYNOTE LECTURE 15:00-15:20 Hereditary cancer genetics in the era of targeted therapies Dr. Karen H. Lu Professor and Chair H.E.B. Professorship in Cancer Research Department Gynecologic Oncology & Reproductive Medicine 15:20-15:30 Discussion 15:30-16:00 INAUGURATION BY AUTHORITIES Wednesday, February 24 th, 2016
3 Wednesday, February 24 th, 2016 FROM LABORATORY MEDICINE TO INNOVATIVE CLINICAL APPLICATIONS: FOSTERING INNOVATION IN CONVERTING RESEARCH DISCOVERIES TO CLINICAL IMPACT Dr. Gema Moreno Dr. José Palacios Hospital Universitario Ramón y Cajal. Madrid, Spain Dr. Ignacio Romero Fundación Instituto Valenciano de Oncología. Valencia, Spain 16:00-16:20 Intra-tumor heterogeneity: Biological and clinical implications Dr. José Palacios Hospital Universitario Ramón y Cajal. Madrid, Spain 16:20-16:40 Gene panel testing in gynecological cancer: From the lab to the clinical practice Dr. Gema Moreno 16:40-17:00 Clinical implications of molecular analysis of serous effusions in ovarian cancer Dr. Ben Davidson The Norwegian Radium Hospital. Oslo, Norway 17:00-17:15 Discussion 17:15-17:45 Coffee break 17:45-18:05 Immunostimulatory monoclonal antibodies changing the landscape of gyn-cancer treatment Dr. Ignacio Melero Clínica Universidad de Navarra. Pamplona, Spain 18:05-18:25 Targeting angiogenesis in ovarian cancer: Overcoming adaptive responses Dr. Anil Sood 18:25-18:45 Harnessing homologous recombination deficiency for specialized treatment of ovarian cancer patients Dr. Robert L. Coleman 18:45-19:00 Endpoints in ovarian cancer trials: Insights from the 2015 SGO/ASCO/AACR FDA endpoints workshop Dr. Robert L. Coleman 19:00-19:15 Discussion INDIVIDUALIZING THERAPY IN ADVANCED OVARIAN CANCER Kliniken Essen Mitte. Essen, Germany Dr. Sergio Martínez Hospital Clínic Universitari. Barcelona, Spain 08:30-08:50 Assessment of quality in ovarian cancer surgery: The ESGO perspective Dr. Denis Querleu Institut Bergonié. Bordeaux, France 08:50-09:10 Laparoscopic evaluation to assess cytoreduction Dr. Anna Fagotti Catholic University of the Sacred Heart. Rome, Italy 09:10-09:30 Clinical and radiologic assessment of feasibility of cytoreduction Dr. Giovanni Aletti Istituto Europeo di Oncologia. Milan, Italy 09:30-09:50 Predictors of residual disease in patients with ovarian cancer Dr. Anil Sood 09:50-10:10 Adjuvant therapy in advanced ovarian cancer: Moving beyond carboplatin and paclitaxel Dr. Christian Marth Medical University Innsbruck, Austria 10:10-10:40 Discussion 10:40-11:10 Coffee break Thursday, February 25 th, 2016
4 INTEGRATING RECENT ADVANCES INTO OPTIMIZING TREATMENT FOR WOMEN WITH RECURRENT OVARIAN CANCER Dr. Andrés Poveda Fundación Instituto Valenciano de Oncología. Valencia, Spain Dr. Sandro Pignata National Cancer Institute Fondazione Pascale. Naples, Italy SENTINEL LYMPH NODE IN GYNECOLOGIC ONCOLOGY: A TIME TO SET NEW STANDARD OF CARE Dr. Jordi Ponce Hospital Universitari de Bellvitge, L Hospitalet de Llobregat. Barcelona, Spain Dr. Michael M. Frumovitz Dr. Pedro F. Escobar Instituto Gyneco-Oncológico. San Juan, Puerto Rico Thursday, February 25 th, :10-11:30 Selecting the really ideal patient for secondary cytoreduction Kliniken Essen Mitte. Essen, Germany 11:30-11:50 Chemotherapy in the recurrent ovarian cancer setting: Relying on the old standard or is novel therapy the new standard? Dr. Sandro Pignata National Cancer Institute Fondazione Pascale. Naples, Italy 11:50-12:10 Critical review of PARPi s in ovarian cancer therapy: How are we going to use them and when? Dr. Jonathan A. Ledermann UCL Cancer Institute, University College. London, United Kingdom 12:10-12:30 Integrating biological therapies in recurrent disease: Looking for the perfect algorithm Dr. Eric Pujade-Lauraine Hôpital Hôtel-Dieu. Paris, France 12:30-13:00 Discussion 13:00-14:40 Lunch 14:40-15:00 Cervical cancer: Can we stop performing complete lymphadenectomy? Dr. David Cibula General University Hospital in Prague, Charles University. Prague, The Czech Republic 15:00-15:40 Endometrial cancer: Memorial Sloan-Kettering vs. Mayo Clinic Dr. Nadeem R. Abu-Rustum Dr. Andrea Mariani Mayo Clinic, Rochester. Minnesota, USA 15:40-16:00 Vulvar cancer: Updates on current data and future trials Dr. Ate Van der Zee University Medical Center of Groningen, Netherlands 16:00-16:20 Discussion 16:20-16:40 Personalizing targeted therapy in advanced/metastatic cervical cancer: The challenge of anti-angiogenesis therapy Dr. Ana Oaknin Hospital General Vall d Hebron. Barcelona, Spain 16:40-16:50 Discussion 16:50-17:10 Coffee break Thursday, February 25 th, 2016
5 Thursday, February 25 th, 2016 UPDATES ON THE MANAGEMENT OF ENDOMETRIAL CANCER Dr. Natalia Carballo Dr. Andrés Redondo Hospital Universitario La Paz. Madrid, Spain Dr. Matías Jurado Clínica Universidad de Navarra. Pamplona, Spain 17:10-17:30 Current and future clinical trials in advanced/recurrent endometrial cancer Dr. Mansoor R. Mirza Rigshospitalet, Copenhagen University Hospital. Copenhagen, Denmark 17:30-17:50 Updates on standard care and novel approaches for radiation oncology in uterine cancer Dr. Anuja Jhingran 17:50-18:10 Reaching a consensus in endometrial cancer: European guidelines (ESGO-ESTRO-ESMO) Dr. Nicoletta Colombo Istituto Europeo di Oncologia. Milan, Italy 18:10-18:30 Discussion Moderator: PERSONALIZED MEDICINE IN GYNECOLOGIC ONCOLOGY: LOOKING BEYOND STANDARDS Dr. Karen H. Lu 08:30-08:45 Targeting stress neuroendocrine pathways in cancer Dr. Anil Sood 08:45-09:00 Enhance recovery after surgery (ERAS) 09:00-09:20 Impact of early integration of palliative medicine in the course of oncology treatment Dr. Carlos Centeno Clínica Universidad de Navarra. Pamplona, Spain 09:20-09:30 Discussion 09:30-10:45 TUMOR BOARD Panel: Dr. David Gershenson Dr. Karen H. Lu Dr. Nadeem R. Abu-Rustum Dr. Nicoletta Colombo Dr. Anuja Jhingran Dr. José Palacios Dr. Pedro F. Escobar Friday, February 26 th, 2016 Presenters: 1. Endometrial cancer with synchronous ovarian carcinoma? Dr. Nadeem R. Abu-Rustum 2. A challenging locally advanced cervical cancer, Dr. Fernando Lapuente 3. Serous carcinoma of the ovary in two different clinical scenarios
6 Friday, February 26 th, :45-11:15 MD ANDERSON SPAIN FOUNDATION AWARDS A life devoted to a great endeavour: Gynecologic oncology Kliniken Essen Mitte. Essen, Germany 11:15-11:45 Coffee break INNOVATIONS IN MINIMALLY INVASIVE SURGERY Dr. Michael M. Frumovitz 11:45-12:05 Update on robotic surgery in gynecologic oncology Dr. Mario M. Leitao 12:05-12:25 Role of single-port surgery by laparoscopy or robotics: Surgical innovation or a procedure without a future? Dr. Pedro F. Escobar Instituto Gyneco-Oncológico. San Juan, Puerto Rico 12:25-12:45 Discussion 12:45-13:45 SURGICAL FILM FESTIVAL Dr. Mario M. Leitao Dr. David Cibula General University Hospital in Prague, Charles University. Prague, The Czech Republic Laparoscopic contained power morcellation: techniques to avoid tumoral spread Dr. Ignacio Zapardiel, Dr. Javier De Santiago Hospital Universitario La Paz. Madrid, Spain Cytoreductive surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer Dr. Gloria Cordeiro, Dr. Babin Guillaume, Dr. Denis Querleu, Dr. Guyon Frédéric Institut Bergonié, Regional Comprehensive Cancer Center. Bordeaux-Aquitaine, France Cava vein injury during lymph node dissection Dr. Julián Di Guilmi, Dr. C. Darin, Dr. AG. Maya Hospital Británico de Buenos Aires, Argentina Sentinel node in vulva cancer Dr. Mario M. Leitao Modified rectus abdominis flap for pelvic floor reconstruction after exenteration Dr. David Cibula, Dr. M. Schneiderova, Dr. J. Slama, Dr. M. Zikan General University Hospital in Prague, Charles University. Prague, The Czech Republic 13:45-13:55 CLOSING REMARKS Ultra-radical laparoscopic abdominopelvic procedures Dr. Nicanor Barrena Pontificia Universidad Católica de Chile, Santiago de Chile Total pelvic exenteration plus IORT in recurrent cervical cancer Dr. Teresa Castellanos, Dr. Sonsoles Alonso, Dr. Fernando Lapuente, Vascular complication of left renal vein Dr. Carlos Millán Instituto Icera. Murcia, Spain Local Committee: Lucía Almeida Sonsoles Alonso Marisa Argente Elsa Bernal Raquel Bratos Natalia Carballo Teresa Castellanos Luis M. Chiva Virginia Corraliza Marta de la Fuente Irene Fernández Juan Fernando García Javier García Prado Antonio González-Martín Luis Granados Fernando Lapuente Pilar López Mendo Raúl Márquez Mar Mendivil Manuel Morales Gema Moreno Mª Jesús Pablos José Antonio Pérez Álvarez Gemma Toledo Covadonga Vidal
7
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Madrid, 9 th -11 th May, 2018 PRELIMINARY PROGRAM Meeting Directors: Registrations: www.mdanderson.es/embracingnewstandards
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Madrid, 9 th -11 th May, 2018 PRELIMINARY PROGRAM Meeting Directors: Registrations: www.mdanderson.es/embracingnewstandards
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
ENYGO REPORT. Summary
ENYGO REPORT Summary The first ENYGO Workshop on Fertility Sparing in Gynaecological Oncology was held at La Paz University Hospital in Madrid (Spain) from 27 to 28 January 2017. It was a very successful
NSGO Annual Meeting 2019
Nordic Society of Gynaecological Oncology NSGO Annual Meeting 2019 Radisson Blu Scandinavia Hotel Amager Blvd. 70, 2300 Copenhagen Theme: Advances in the Management of Gynaecological Cancer Patients 27
Progress and Controversies in Gynecologic Oncology Conference
2013 This meeting is a prime Oncology activity. Progress and Controversies in Gynecologic Oncology Conference 15-16 February 2013 Haliç Congress Center Istanbul, Turkey www.primeoncology.org/gyncongress2013
NSGO Annual Meeting 2019
Nordic Society of Gynaecological Oncology NSGO Annual Meeting 2019 Radisson Blu Scandinavia Hotel Amager Blvd. 70, 2300 Copenhagen Theme: Advances in the Management of Gynaecological Cancer Patients 27
Gastrointestinal Oncology
2 nd MD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era of Personalized Medicine e Madrid, 13 th -15 th November, 2019 SCIENTIFIC PROGRAM Meeting
NSGO Annual Meeting 2019
Nordic Society of Gynaecological Oncology NSGO Annual Meeting 2019 Radisson Blu Scandinavia Hotel Amager Blvd. 70, 2300 Copenhagen Theme: Advances in the Management of Gynaecological Cancer Patients 28
Progress and Controversies in Gynecologic Oncology Conference
2012 Progress and Controversies in Gynecologic Oncology Conference 13-14 April 2012 Hotel Fira Pa la ce Ba rcelona, Spain A prime Oncology activity. www.primeoncology.org/gyncongress2012 Welcome On behalf
Gastrointestinal Oncology
1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era ra o f Pe Perss on onal aliz ized ed M edicine PRELIMINARY PROGRAM Madrid, 29 November -
VULVAR CANCER QUALITY INDICATORS
VULVAR CANCER QUALITY INDICATORS www.esgo.org The European Society of Gynaecological Oncology (ESGO) has developed a list of quality indicators for vulvar surgery that can be used to audit and improve
Pre-Congress Course on Radical Vulvar Surgery Tampere Surgical Education Centre (TSEC)
Wednesday 3 May 2017 08.00 14.00 Pre-Congress Course on Radical Vulvar Surgery Tampere Surgical Education Centre (TSEC) 12.00 15.00 Visit to the Helsinki University Central Hospital, Department of Radiotherapy
ECC or Margins Positive?
CLINICAL PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson,
ADVANCED (STAGE III-IV) OVARIAN CANCER SURGERY QUALITY INDICATORS
ADVANCED (STAGE III-IV) OVARIAN CANCER SURGERY QUALITY INDICATORS www.esgo.org Ovarian cancer is the leading cause of death among all gynecologic cancers and remains the most common cause of death for
QUALITY INDICATORS ADVANCED (STAGE III-IV) OVARIAN CANCER SURGERY - QUALITY INDICATORS
ADVANCED (STAGE III-IV) OVARIAN CANCER SURGERY QUALITY INDICATORS 1 Ovarian cancer is the leading cause of death among all gynecologic cancers and remains the most common cause of death for 15 years after
SLN Mapping in Cervical Cancer. Memorial Sloan Kettering Cancer Center New York, USA
Lead Grou p Log SLN Mapping in Cervical Cancer Nadeem R. Abu-Rustum, M.D. Memorial Sloan Kettering Cancer Center New York, USA Conflict of Interest Disclosure Nadeem R. Abu-Rustum, M.D. I have no financial
Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd
Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto
Ovarian Cancer Surgery Pocket Guidelines
Ovarian Cancer Surgery Pocket Guidelines guidelines.esgo.org 2 POCKET GUIDELINES OVARIAN CANCER SURGERY based on ESGO Guidelines for Ovarian Cancer Surgery Querleu, D., Planchamp, F., Chiva, L., Fotopoulou,
COURSES ENDORSEMENT AND ACCREDITATION
COURSES ENDORSEMENT AND ACCREDITATION This course is organized in partnership with ESGO. This course meets the guidelines established in the "SAGES Framework for Post-Residency Surgical Education and Training"
BGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford
Thursday 5 th July Time Session Location 7:30-9:20 Registration 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford 8:00-9:00 INDUSTRY SPONSORED MEETING Wesley 9:20-9:30 Welcome and introduction Mr Tim Mould
This meeting has been made possible by an independent grant from Roche.
This meeting has been made possible by an independent grant from Roche. This event has been created in collaboration between the University of Milan and ecancer. MILAN SUMMIT ON PRECISION MEDICINE AGENDA
CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE
CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE BARCELONA 14-15 January 2016 HOSPITAL DEL MAR Passeig Marítim, 25-29 Barcelona 08003 PROGRAM WITH SIMULTANEOUS TRANSLATION Faculty COORDINATORS Giménez-Arnau,
Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain
CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo
BGCS Thursday 5 th July. Time Session Location 7:30-9:30 Registration. Cervical Cancer Control in the UK now and in the future
Thursday 5 th July 7:30-9:30 Registration 8:35-9:20 Dynamic Fluorescent Imaging In Gynaecological Oncology Surgery Meeting sponsored by Stryker Rutherford 8:35-9:20 Cervical Cancer Control in the UK now
MD Anderson Cancer Center. Madrid. España - Madrid, Spain
- Madrid, Spain General Information New breast cancer cases treated per year 280 Breast multidisciplinarity team members 14 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
BGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford
Thursday 5 th July Time Session Location 7:30-9:20 Registration 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford 8:00-9:00 INDUSTRY SPONSORED MEETING Wesley 9:20-9:30 Welcome and introduction Mr Tim Mould
Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective
第 53 回日本癌治療学会学術集会 ASCO, ESMO, ECCO からの招聘演者と講演予定 Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective Ralf A. Stahel (President
Invasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous
Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Find Studies About Studies Submit Studies Resources About Site Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer The safety and scientific validity of this study is
PROGRAMME April 26 th & 27 th 2019
PROGRAMME April 26 th & 27 th 2019 LIVE SURGERY REJUVENATION WORKSHOPS Dr Ramón Medel IMO barcelonaoculoplastics.com ORGANIZING COMMITTEE Dr Ramón Medel Dr Juan Carlos Sánchez Dr Luz María Vásquez NATIONAL
5 th International Video Workshop
Sponsorship and Exhibition Prospectus 5 th International Video Workshop on Radical Surgery in Gynaecological Oncology April 21-23, 2016 Prague Czech Republic Dear business partners, It is my great pleasure
Treating today s patients with tomorrow s solutions
Treating today s patients with tomorrow s solutions 1st conference supported by: European Multidisciplinary Breast Cancer Collaborative (EMBCC) February 5-6, 2016 Maison des oceans Paris EMBCC board members
Ovarian Cancer Conference
Memorial Sloan Kettering Cancer Center is pleased to announce: State of the Art Ovarian Cancer Conference Thursday, October 6, 2016 www.mskcc.org/ovarianconference Course Overview Advances in women s health
How to Define, Evaluate, and Identify Surgical Quality. Viewpoint of the ESGO Quality Assurance Committee
How to Define, Evaluate, and Identify Surgical Quality Viewpoint of the ESGO Quality Assurance Committee Giovanni Aletti, MD European Institute of Oncology Milan, Italy The best interest of the patient
ESPNIC Endorsed Advanced Simulation Course. Program
ESPNIC Endorsed Advanced Simulation Course Technological Training Center, La Coruña (Spain), 25 th & 26 th April 2019 Thursday, 25 April 2019 Program Time Activity Instructor/Speaker 8.30-8.45 Presentation,
Residual Tumor Following Surgery: The Strongest Prognostic Factor or a Myth? Philipp Harter, MD Kliniken Essen Mitte Essen, Germany
Residual Tumor Following Surgery: The Strongest Prognostic Factor or a Myth? Philipp Harter, MD Kliniken Essen Mitte Essen, Germany What Are Our Questions Q1: Prognostic factor residual disease? Q2: Differences
With the Presidency of Her Majesty the Queen Sofia
ay, 21 st 10:00-15:00 Welcome and registration. Posters set-up With the Presidency of Her Majesty the Queen Sofia 12:00-12:15 OFFICIAL OPENING 12:15-13:15 KEYNOTE LECTURE Introduced by: Jesús Ávila. Bengt
II CANCER CELL SIGNALING PATHWAYS CONFERENCE
II CANCER CELL SIGNALING PATHWAYS CONFERENCE AN IN DEPTH LOOK AT LUNG, MELANOMA, GLIOBLASTOMA, BREAST, HEAD & NECK SQUAMOUS CELL CANCERS Fundació Institut d Investigació en Ciències de la Salut Germans
Colorectal Cancer Multidisciplinary management, standards of care and future perspectives
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
OBJECTIVES OF THE MEETING
OBJECTIVES OF THE MEETING The Second European LAM Conference is an international meeting with the purpose of getting insights into the new results of research and sharing with patient s community and educational
21-23 CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS CONGRESS
IV CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS IV INTERNATIONAL ON RESEARCH AND INNOVATION IN IVNEURODEGENERATIVE DISEASES IV CONGRESS ALICANTE 2016 Septiembre
BEATcc Trial: ENGOT-Cx10 / GEICO 68-C / JGOG1084. GCIG Meeting
BEATcc Trial: ENGOT-Cx10 / GEICO 68-C / JGOG1084 GCIG Meeting Ana Oaknin, MD PhD Head of Gynecologic Cancer Program. Vall d Hebron Institute of Oncology(VHIO). Vall d Hebron University Hospital. GEICO
Beate Rau, Charité University of Berlin Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR
Chairs Beate Rau, Charité University of Berlin Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR Faculty members Frédéric Bibeau, Caen University
Disclosure. No Conflicts of Interest
Phase III Randomized Trial of Laparoscopic or Robotic Radical Hysterectomy vs. Abdominal Radical Hysterectomy in Patients with Early-Stage Cervical Cancer: LACC Trial Pedro T. Ramirez, Michael Frumovitz,
Para-aortic laparoscopic lymph-node dissection for advanced cervical cancers
Para-aortic laparoscopic lymph-node dissection for advanced cervical cancers P. Mathevet, Hôpital Femme-Mère-Enfant, Bron Lymph-node involvement Is one of the major prognostic factor in gynecologic cancers.
FIRST CANCER CELL SIGNALING PATHWAYS MEETING
FIRST CANCER CELL SIGNALING PATHWAYS MEETING AN IN DEPTH LOOK AT TRENDS IN POLY-TARGETED LUNG CANCER THERAPY Institut Germans Trias i Pujol (IGTP), Conference Meeting Room, Badalona, Barcelona, Spain -
Shift your surgical ambition to surgical action
Dates: February 1-3, 2018 3th International Meeting ENDO-Dubai : Updates in Minimal Invasive surgery in Gynecology Shift your surgical ambition to surgical action AGENDA AT A GLANCE Thursday, February
INCIDENCE OF ADVERSE EVENTS COMPARING ABDOMINAL VS. MINIMALLY INVASIVE RADICAL HYSTERECTOMY IN PATIENTS WITH EARLY-STAGE CERVICAL CANCER: LACC TRIAL
INCIDENCE OF ADVERSE EVENTS COMPARING ABDOMINAL VS. MINIMALLY INVASIVE RADICAL HYSTERECTOMY IN PATIENTS WITH EARLY-STAGE CERVICAL CANCER: LACC TRIAL Andreas Obermair, Rebecca Asher, Michael Frumovitz,
CHAIRMAN. - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain FACULTY
CHAIRMAN - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain FACULTY - Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, New York, USA - Emilio
Cómo Incorporar la Terapia Antiangiogénica en el Cáncer de Ovario? XIV Congreso Nacional Salamanca Octubre de 2013 SESION CONTROVERSIA-1 15,45-17H
Cómo Incorporar la Terapia Antiangiogénica en el Cáncer de Ovario? XIV Congreso Nacional Salamanca Octubre de 2013 SESION CONTROVERSIA-1 15,45-17H Andres Poveda Fundación Instituto Valenciano de Oncología
Faculty. Silvia Allende, MD Paulina Núñez, MD Raúl Ramírez, MD Gabriel Santiago, MD Nidia Zapata, MD
Justification Breast cancer stands out as the primary cause of death due to tumors in emerging countries where most cases are diagnosed in advanced stages, hindering their successful treatment. In Mexico,
Dr. Sergi Call Caja Thoracic Surgery Service
Dr. Sergi Call Caja Thoracic Surgery Service Introduction 1. Use of Lymphadenectomy in Lung Metastasectomy? 2. Incidence of lymph node metastases (LNM)? 3. What is the Impact on Survival? Introduction
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT madrid 22nd-23th march 2012 Course Director MODERATORS AND FACULTY PANNEL R. Larrainzar Hospital U. Infanta Leonor O. Marín Peña Hospital U. Infanta
URO. I International Workshop PEYRONIE S DISEASE UPDATED PATTERNS IN CONSERVATIVE MANAGEMENT AND SURGICAL TREATMENT OF. MADRID, 18th JUNE 2015
I International Workshop UPDATED PATTERNS IN CONSERVATIVE MANAGEMENT AND SURGICAL TREATMENT OF PEYRONIE S DISEASE URO 2015 MADRID, 18th JUNE 2015 Hospital Course Directors: Juan Ignacio Martínez-Salamanca.
Beate Rau, Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR
Chairs Beate Rau, Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR Faculty members Salah-Eddin Al-Batran, Institut für Klinisch-Onchologische
ESSO Course on Diagnosis and Treatment of Pancreatic NeuroEndocrine Tumours (PNETs)
ESSO Course on Diagnosis and Treatment of Pancreatic NeuroEndocrine Tumours (PNETs) 26-27 May 2016 LONDON (UK) ESSO Course on Diagnosis and Management of Pancreatic Neuro-Endocrine Tumours (PNETs) Chairs
BARIATRIC AND METABOLIC SURGERY
WEDNESDAY, OCTOBER 15, 2014 REVISIONAL BARIATRIC SURGERY AND ENDOSCOPY SYMPOSIUM Hospital Clínico San Carlos, Auditorium. Madrid Live Procedures Endoscopic re-sizing of gastro-jejunal anastomosis for dumping
Madrid, 15 th - 16 th November Meeting Venue: Paseo de la Castellana 33, Madrid
Madrid, 15 th - 16 th November 2018 Meeting Venue: Paseo de la Castellana 33, Madrid MORNING (9:00h - 14:00h) Thursday, November 15 th 2018 Low ovarian reserve Chairman: Laura de la Fuente 08:00-08:30
ESGO 16 PRESS RELEASE. October 11-14, 2009 Belgrade, Serbia 10 STORIES WITH DATA ANNOUNCEMENTS
ESGO 16 October 11-14, 2009 Belgrade, Serbia PRESS RELEASE 10 STORIES WITH DATA ANNOUNCEMENTS GYNAECOLOGICAL CANCER TREATMENT ENTERS NEW ERA OF PATIENT-TAILORED CARE Advances in cancer prevention and treatment
ESSO Advanced Course on Breast Cancer Surgery
ESSO Advanced Course on Breast Cancer Surgery 08-10 October 2015 LISBON In Partnership with ESSO Advanced Course on Breast Cancer Surgery Chairs Marjut Leidenius, Helsinki University Central Hospital,
SCIENTIFIC and SOCIAL PROGRAM
4th European Days of Albinism, 7-11 March 2018 Hurdal Vision and Activity Center, Oslo, Norway Organized by Albinism Europe and NFFA SCIENTIFIC and SOCIAL PROGRAM Wednesday, 7 March 2018-17:00 SHUTTLE
Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)
ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Prague, Czech Republic 22-26 October 2016 Course Directors: Richard
Index. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)
ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Prague, Czech Republic 22-26 October 2017 Course Directors: Richard
RECTAL MRI WORKSHOP. One Workstation Per Participant - Space is limited! Includes Complimentary Registration to the Colorectal Centennial Symposium
RECTAL MRI WORKSHOP THURSDAY, NOVEMBER 9, 2017 Zuckerman Research Center, New York City One Workstation Per Participant - Space is limited! Includes Complimentary Registration to the Colorectal Centennial
Invitation from Chongqing, China.
Invitation from Chongqing, China. Dear Colleagues, You are cordially invited to join us for the AAGL Regional Meeting on Minimally Invasive Gynecology, in Chongqing, China, April 18 20. 2014. With the
WELCOME. Dear colleagues,
WELCOME Dear colleagues, It is a great pleasure to invite you to take part in the Second Edition of the International Course of Airway and Thoracic Malformations in Paediatrics, to be held on 1-2 October
Beate Rau, Charité Campus Berlin, Berlin, DE Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK
Chairs Beate Rau, Charité Campus Berlin, Berlin, DE Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK Faculty members Andreas Brandl, Charité Campus Berlin, Berlin, DE James Coakes,
RIA N CA C N A C N E C R E SU R RGE
OVARIAN ANER SURGERY GUIDELINES These guidelines are focused on the role, objectives, and standards of the surgical management of diagnosed epithelial ovarian, fallopian tube and peritoneal cancer. The
From Research to Practice: What s New in Gynecologic Cancers?
From Research to Practice: What s New in Gynecologic Cancers? David Warshal, M.D. Head, Division of Gynecologic Oncology MD Anderson Cooper Cancer Institute Associate Professor of Obstetrics and Gynecology
13 th ANNUAL MEETING Siracusa, Sicily, ITALY October 4-6, Hotel des Etrangers Passeggio Adorno 10/12, Siracusa, Italy
13 th ANNUAL MEETING Siracusa, Sicily, ITALY October 4-6, 2015 Hotel des Etrangers Passeggio Adorno 10/12, 96100 Siracusa, Italy OCTOBER 4 th, 2015 Time Event/Speaker Topic 2:00 6:00 pm Registration 3:30
ESMO Symposium on Immuno-Oncology Programme book
IMMUNO-ONCOLOGY SYMPOSIUM ESMO Symposium on Immuno-Oncology Programme book Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies Geneva Switzerland 15-16 NOVEMBER 2013 esmo.org
Programme - Wednesday, 5 September
Programme - Wednesday, 5 September 15th Meeting of the EAU Robotic Urology Section Room: Auditorium Actual programme might be subject to change due to live surgery Live broadcasts from Institut Paoli-Calmettes
Target audience. Jorge Correale Department of Neurology Raúl Carrea Institute for Neurological Research (FLENI) Buenos Aires, Argentina
EXCEMED Blended Education Immune and clinical profiling in multiple sclerosis: laying groundwork for advanced approaches to treatment Live intervention in PRELIMINARY PROGRAMME Immune and clinical profiling
SCIENTIFIC and SOCIAL PROGRAM
4th European Days of Albinism, 7-11 March 2018 Hurdal Vision and Activity Center, Oslo, Norway Organized by Albinism Europe and NFFA SCIENTIFIC and SOCIAL PROGRAM Wednesday, 7 March 2018 Airport shuttle
Vulvar Cancer Pocket Guidelines
Vulvar ancer Pocket Guidelines guidelines.esgo.org 2 POKET GUIDELINES VULVAR ANER based on ESGO Guidelines for the Management of Patients with Vulvar ancer Oonk, M. H. M., Planchamp, F., Baldwin, P., Bidzinski,
Saturday, 13 February 2016
Saturday, 13 February 2016 16.10 16.15 Opening and welcome C.R. Chapple, Sheffield (GB) 16.15 18.00 What is new in urology 1 Chairs: C. R. Chapple, Sheffield (GB) 16.15 16.35 Functional urology C. Gratzke,
Program Schedule. Update in Gynecology and Minimally Invasive Surgery 2018
Program Schedule Update in Gynecology and Minimally Invasive Surgery 2018 Wednesday, February 7, 2018 6:00 a.m. Registration & Breakfast with Exhibitors 6:55 a.m. Welcome Announcements SESSION: Practical
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT madrid 22nd-23th march 2012 R. Larrainzar Hospital U. Infanta Leonor Madrid (spain) Course Director O. Marín Peña Hospital U. Infanta Leonor Madrid
Robotic Advances in Gynecology
Robotic Advances in Gynecology September 4-5, 2014 MD Anderson, Dan L. Duncan Building Conference Center, Floor 8 1155 Pressler Street Houston, Texas In Collaboration With: Robotic Advances in Gynecology
Program. (April 21 version, still tentative) PLEASE NOTE
49th Husserl Circle Meeting Casa Universitaria del Libro Mexico City 26-29 June, 2018 Program (April 21 version, still tentative) PLEASE NOTE - All sessions will be in the SALÓN DE VIDEOCONFERENCIAS, located
MENTOR Course in Surgical Excellence:
MENTOR Course in Surgical Excellence: Managing Complications and Revision Surgery April 23 rd -24 th, 2015 Beurs van Berlage Amsterdam, The Netherlands Managing Complications and Revision Surgery Objective
Ovarian cancer: clinical practice the Arabic perspective
Lead Group Log Ovarian cancer: clinical practice the Arabic perspective Experience of Hôtel-Dieu de France University Hospital (Beirut, LEBANON) in supraradical surgery for ovarian cancer David ATALLAH
Course Directors : Teaching Staff : Guest Lecturer: Local Organiser: ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL)
ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Florence, Italy 28 September -2 October 2014 Course Directors
th International Charité Mayo Conference
PREPUBLICATION SCIENTIFIC PROGRAM v 10 Global Perspectives and Future Directions in Women s Cancer April 3 6, 2019 Berlin th International Charité Mayo Conference CALL FOR ABSTRACTS www.charite-mayo.de
FIRST ANNUAL ORLANDO COLORECTAL CONGRESS LIVE! November 8-10, 2017
FIRST ANNUAL ORLANDO COLORECTAL CONGRESS LIVE! November 8-10, 2017 Florida Hospital Nicholson Center 404 Celebration Place Celebration, FL 34747 Featuring: Presented by: Center for Colon & Rectal Surgery
CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves Douillard, France
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
THE PSA AND PROSTATE CANCER DILEMMA
IV CLINICAL UROLOGY MEETING THE PSA AND PROSTATE CANCER DILEMMA BILBAO February 23-24, 2017 Clínica IMQ Zorrotzaurre Organized by: SOME REASONS TO ATTEND OUR MEETING The PSA test is not a prostate cancer
VULVAR CANCER GUIDELINES
VULVAR ANER GUIDELINES www.esgo.org Broz_210x297_9_16_b.indd 1 13.09.16 21:48 The European Society of Gynaecological Oncology (ESGO) developed guidelines covering diagnosis and referral, preoperative investigations,
:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B
04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture
9th INTERNATIONAL TRAINING COURSE.
9th INTERNATIONAL TRAINING COURSE. MINIMALLY INVASIVE TRANSANAL SURGERY (TEO and TaTME). THE APPLICATION OF INDOCYANINE GREEN 12-13-14 December 2018 Colorectal Unit Parc Tauli University Hospital Sabadell
THURSDAY, 9 JUNE 2016
COMMITTEE Dr. Peter Vorwald. Fundación Jiménez Díaz. Madrid. Dr. Gabriel Salcedo. Fundación Jiménez Díaz. Madrid. Dra. María Posada. Fundación Jiménez Díaz. Madrid. Dr. Damián García Olmo. Grupo Quirón
What Are the Targets in CKD-MBD?
Knowledge Exchange 2016 Paris, France, September 30, 2016 Date of preparation: Nov 2016 Item job code: INTSP/C-ANPROM/FOS/16/0025 Cristina Ortiz Jorge B Cannata-Andía Bone and Mineral Research Unit Hospital
26 November Lima, Perù
PRELIMINARY PROGRAMME 2014 Pre LACTRIMS conference on progressive MS 26 November 2014 - Lima, Perù Dear participant, A warm welcome to all attending the 2014 Pre LACTRIMS conference on progressive MS.
PROGRAMME GLAU COMA 3RDTRENDS IN. International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery. 9 th & 10 th November
PROGRAMME 3RDTRENDS IN GLAU COMA International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery 9 th & 10 th November ORGANIZING COMMITTEE IMO s Glaucoma Department: Dr Elena Arrondo Dr